Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
NPCE
Stock Latest News
Company Announcements
NeuroPace Appoints New CFO Amid Strategic Shift
11d ago
8K
NPCE
Premium
The Fly
NeuroPace CFO Rebecca Kuhn to depart, Patrick Williams to succeed
11d ago
NPCE
STAA
Premium
The Fly
Femasys appoints Nicholas as CCO
18d ago
FEMY
NPCE
Premium
Company Announcements
NeuroPace Holds Virtual Annual Stockholders Meeting
23d ago
8K
NPCE
Premium
Company Announcements
NeuroPace Secures $75 Million Credit Facility with MidCap
1M ago
8K
NPCE
Premium
Ratings
Buy Rating for NeuroPace: Strong Revenue Growth and Efficacy of RNS System Drive Investment Appeal
1M ago
NPCE
Premium
The Fly
NeuroPace initiated with a Buy at H.C. Wainwright
1M ago
NPCE
Premium
Ratings
NeuroPace: Buy Rating Affirmed Amid Promising NAUTILUS Study Outcomes and Favorable FDA Engagement
1M ago
NPCE
Premium
Ratings
Optimistic Outlook for NeuroPace: Buy Rating Justified by Subgroup Success and Growth Potential
1M ago
NPCE
Premium
Ratings
NeuroPace’s Promising Prospects: Buy Rating Affirmed Despite Initial Study Setback
1M ago
NPCE
Premium
The Fly
Leerink says NeuroPace results disappointing, sees hope on totality of data
1M ago
NPCE
Premium
Company Announcements
NeuroPace Announces Promising NAUTILUS Study Results
1M ago
8K
NPCE
Premium
The Fly
NeuroPace NAUTILUS trial met primary 12-week post-implant safety endpoint
1M ago
NPCE
Premium
Company Announcements
NeuroPace, Inc. Reports Strong Q1 2025 Earnings
2M ago
NPCE
Premium
Ratings
NeuroPace: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
2M ago
NPCE
Premium
Company Announcements
NeuroPace Reports Strong Q1 2025 Revenue Growth
2M ago
NPCE
Premium
Ratings
NeuroPace Buy Rating Affirmed on Strong Financials and Strategic Growth Prospects
2M ago
NPCE
Premium
Ratings
NeuroPace: Strong Market Position and Growth Potential Drive Buy Rating
2M ago
NPCE
Premium
The Fly
NeuroPace price target raised to $16 from $14 at JPMorgan
2M ago
NPCE
Premium
The Fly
NeuroPace reports Q1 EPS (21c), consensus (24c)
2M ago
NPCE
Premium
The Fly
NeuroPace sees FY25 revenue $93M-$97M, consensus $93.68M
2M ago
NPCE
Premium
Pre-Earnings
NPCE Upcoming Earnings Report: What to Expect?
2M ago
NPCE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
